CLOV · Clover Health Investments Corp
United States · RS rating 80 · As of 2026-11-03
| Price | 4.29 USD |
|---|---|
| 1-day change | -0.5% |
| RS rating (overall / 1M / 3M / 12M) | 80 / 38 / 74 / 69 |
| Stage | Advancing |
| Composite / Minervini / CANSLIM score | 45 / 66 / 52 |
| Industry group (rank) | Medical-Managed Care (13) |
| EPS growth Q/Q | +150.0% |
| Sales growth Q/Q | -1.8% |
| Distance from 52-week high | +20.7% |
| Market cap (USD) | $1.3B |